Vibrac Launches a Chewable and Divisible Tablet to Treat Cushing's Disease

Virbac, a veterinary pharmaceutical company, has launched Trilotab, a new medication for treating Cushing's disease in dogs. Unlike Vetoryl, each Trilotab tablet can be divided, which makes it easier to tailor to a dog's needed dose. It's also flavored and chewable.

Please note, Trilotab is currently only available in the UK and European Union. For more information, please see the following:

Trilotab, the First Chewable, Flavoured & Divisible Trilostane Tablet to Treat Cushing’s Syndrome in Dogs

Trilotab Detailer by Virbac

Trilotab Details by Veterinary Medicines Directorate

Trilotab Details by the European Medicines Agency